Exploiting HIV-1 protease and reverse transcriptase cross-resistance information for improved drug resistance prediction by means of multi-label classification

被引：0
|
作者：
Mona Riemenschneider
Robin Senge
Ursula Neumann
Eyke Hüllermeier
Dominik Heider
机构：
[1] Straubing Center of Science,Department of Bioinformatics
[2] University of Paderborn,Department of Computer Science
[3] Technische Universität München,Wissenschaftszentrum Weihenstephan
[4] University of Applied Science Weihenstephan-Triesdorf,undefined
来源：
BioData Mining | / 9卷
关键词：
Infectious diseases; Machine learning; Retrovirus; HIV therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Genetic and antiretroviral drug resistance mutations analysis of reverse transcriptase and protease gene from Pakistani people living with HIV-1
    Siddiqui, Dilsha
    Badar, Uzma
    Javaid, Mahnoor
    Farooqui, Nida
    Shah, Sharaf Ali
    Iftikhar, Ayesha
    Sultan, Faisal
    Mir, Fatima
    Furqan, Sofia
    Mahmood, Syed Faisal
    Abidi, Syed Hani
    PLOS ONE, 2023, 18 (08):
  • [42] Identification of insertion mutations in HIV-1 reverse transcriptase causing multiple drug resistance to nucleoside analogue reverse transcriptase inhibitors
    Sugiura, W
    Matsuda, M
    Matsuda, Z
    Abumi, H
    Okano, A
    Oishi, T
    Moriya, K
    Yamamoto, T
    Fukutake, K
    Mimaya, J
    Ajisawa, A
    Taki, M
    Yamada, K
    Nagai, Y
    JOURNAL OF HUMAN VIROLOGY, 1999, 2 (03) : 146 - 153
  • [43] Prediction and molecular field view of drug resistance in HIV-1 protease mutants
    Baifan Wang
    Yinwu He
    Xin Wen
    Zhen Xi
    Scientific Reports, 12
  • [44] Prediction and molecular field view of drug resistance in HIV-1 protease mutants
    Wang, Baifan
    He, Yinwu
    Wen, Xin
    Xi, Zhen
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [45] Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.
    Hopkins, AL
    Ren, JS
    Milton, J
    Hazen, RJ
    Chan, JH
    Stuart, DI
    Stammers, DK
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (24) : 5912 - 5922
  • [46] Nevirapine-selected mutations Y181I/C of HIV-1 reverse transcriptase confer cross-resistance to stavudine
    Baldanti, F
    Paolucci, S
    Maga, G
    Labo, N
    Hübscher, U
    Skoblov, AY
    Victorova, L
    Spadari, S
    Minoli, L
    Gerna, G
    AIDS, 2003, 17 (10) : 1568 - 1570
  • [47] Multidrug-resistant HIV-1 reverse transcriptase:: Involvement of ribonucleotide-dependent phosphorolysis in cross-resistance to nucleoside analogue inhibitors
    Mas, A
    Vázquez-Alvarez, BM
    Domingo, E
    Menéndez-Arias, L
    JOURNAL OF MOLECULAR BIOLOGY, 2002, 323 (02) : 181 - 197
  • [48] Novel diarylpyrimidine subtypes as HIV-1 nonnucleoside reverse transcriptase inhibitors with improved resistance profile
    Wang, Zhengqiang
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (03)
  • [49] The Lysine 65 Residue in HIV-1 Reverse Transcriptase Function and in Nucleoside Analog Drug Resistance
    Garforth, Scott J.
    Lwatula, Chisanga
    Prasad, Vinayaka R.
    VIRUSES-BASEL, 2014, 6 (10): : 4080 - 4094
  • [50] Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
    Mark J. Siedner
    Michelle A. Moorhouse
    Bryony Simmons
    Tulio de Oliveira
    Richard Lessells
    Jennifer Giandhari
    Stephen A. Kemp
    Benjamin Chimukangara
    Godspower Akpomiemie
    Celicia M. Serenata
    Willem D. F. Venter
    Andrew Hill
    Ravindra K. Gupta
    Nature Communications, 11
12345